Trial intelligence / Profile preview

INASED: Inhaled vs intravenous sedation in mechanically ventilated ICU patients

2024-513530-37-00Phase 3Authorised

Sponsor
Centre Hospitalier Universitaire de Brest
Start
Aug 2024
Modality
Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of isoflurane and propofol in delirium (2 arms), sponsored by Centre Hospitalier Universitaire de Brest. Primary endpoint: Occurrence of delirium in intensive care unit. Planned start Aug 2024; status: authorised.

02

Drugs

isofluranepropofol
03

Conditions

delirium

Beyond the preview

Go deeper on 2024-513530-37-00.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-513530-37-00.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call